These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16842268)

  • 1. Prospects for recombinant vaccines against Babesia bovis and related parasites.
    Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
    Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune control of Babesia bovis infection.
    Brown WC; Norimine J; Knowles DP; Goff WL
    Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.
    Figueroa JV; Precigout E; Carcy B; Gorenflot A
    Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.
    Combrink MP; Troskie PC; Du Plessis F; Latif AA
    Vet Parasitol; 2010 May; 170(1-2):30-6. PubMed ID: 20207488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens.
    Fish L; Leibovich B; Krigel Y; McElwain T; Shkap V
    Vaccine; 2008 Dec; 26 Suppl 6():G29-33. PubMed ID: 19178890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
    Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
    Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing blood-stage vaccines against Babesia bovis and B. bigemina.
    Brown WC; Palmer GH
    Parasitol Today; 1999 Jul; 15(7):275-81. PubMed ID: 10377530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection.
    Brown WC
    Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for Babesia bovis vaccine candidates.
    Florin-Christensen M; Schnittger L; Dominguez M; Mesplet M; Rodríguez A; Ferreri L; Asenzo G; Wilkowsky S; Farber M; Echaide I; Suarez C
    Parassitologia; 2007 May; 49 Suppl 1():9-12. PubMed ID: 17691600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of older Bos taurus bulls against bovine babesiosis.
    Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
    Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle.
    Brown WC; Palmer GH; McElwain TF; Hines SA; Dobbelaere DA
    Exp Parasitol; 1993 Aug; 77(1):97-110. PubMed ID: 8344411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
    Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
    Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different direct diagnostic methods to identify Babesia bovis and Babesia bigemina in animals vaccinated with live attenuated parasites.
    Costa-Júnior LM; Rabelo EM; Martins Filho OA; Ribeiro MF
    Vet Parasitol; 2006 Jun; 139(1-3):231-6. PubMed ID: 16580136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains.
    Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA
    Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variation as an exploitable weakness of babesial parasites.
    Allred DR; Al-Khedery B
    Vet Parasitol; 2006 May; 138(1-2):50-60. PubMed ID: 16517078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
    Suarez CE; Noh S
    Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisone inhibits in vitro and in vivo propagation of Babesia bovis and B. bigemina parasites.
    Mazuz ML; Golenser J; Fish L; Haynes RK; Wollkomirsky R; Leibovich B; Shkap V
    Exp Parasitol; 2013 Dec; 135(4):690-4. PubMed ID: 24184077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens.
    Delbecq S; Hadj-Kaddour K; Randazzo S; Kleuskens J; Schetters T; Gorenflot A; Précigout E
    Vaccine; 2006 Jan; 24(5):613-21. PubMed ID: 16199111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.